Examkin

Question

Difficulty: HardOrdering Imaging Studies

A 54-year-old man presents to the emergency department with intermittent, colicky right upper quadrant abdominal pain and nausea for the past 48 hours. The pain typically worsens 30 minutes after eating. His temperature is 37.4°C (99.3°F), blood pressure is 130/85 mm Hg, pulse is 88/min, and respiratory rate is 14/min. Physical examination reveals mild right upper quadrant tenderness to deep palpation without guarding or rebound. The Murphy sign is negative. Scleral icterus is not present.

Laboratory studies show:
Leukocyte count: 8,500/mm³
Total bilirubin: 2.2 mg/dL
Direct bilirubin: 1.6 mg/dL
Alkaline phosphatase: 245 U/L
Aspartate aminotransferase (AST): 110 U/L
Alanine aminotransferase (ALT): 135 U/L
Amylase: 45 U/L

Right upper quadrant ultrasonography reveals multiple echogenic foci with posterior acoustic shadowing within the gallbladder. The gallbladder wall measures 2 mm in thickness, and there is no pericholecystic fluid. The common bile duct measures 8 mm in diameter, but no intraluminal stones are visualized.

Which of the following is the most appropriate next step in imaging for this patient?

  1. Magnetic resonance cholangiopancreatography (MRCP)Answer
  2. B
    Endoscopic retrograde cholangiopancreatography (ERCP)
  3. C
    Computed tomography (CT) of the abdomen with intravenous contrast
  4. D
    Hepatobiliary iminodiacetic acid (HIDA) scan
  5. E
    Percutaneous transhepatic cholangiography (PTC)

Answer

Magnetic resonance cholangiopancreatography (MRCP)
The patient has symptomatic cholelithiasis with evidence of common bile duct (CBD) dilation and abnormal liver chemistries, placing him at intermediate risk for choledocholithiasis. According to current consensus guidelines, intermediate-risk patients (defined by abnormal liver function tests, age over 55, or CBD dilation on ultrasound without ascending cholangitis or bilirubin over 4.0 mg/dL) should undergo non-invasive confirmatory imaging prior to invasive therapeutic procedures. Magnetic resonance cholangiopancreatography (MRCP) has excellent sensitivity and specificity for detecting CBD stones and avoids the significant risks of pancreatitis and perforation associated with invasive alternatives.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation, laboratory results, and initial ultrasound findings.
The patient has symptomatic cholelithiasis, elevated total bilirubin (2.2 mg/dL), elevated liver enzymes, and a dilated common bile duct (8 mm) without an explicitly visualized stone.
Accurately identifying objective data is necessary to stratify the patient's risk of choledocholithiasis.
2
Apply risk stratification guidelines for choledocholithiasis.
The patient meets intermediate risk criteria because he has abnormal liver chemistries and a dilated common bile duct on ultrasound, but his total bilirubin is less than 4.0 mg/dL and he lacks clinical signs of ascending cholangitis.
Differentiating between low, intermediate, and high risk dictates whether to proceed directly to surgery, perform non-invasive imaging, or pursue invasive therapeutic intervention.
3
Select the appropriate imaging modality for an intermediate-risk patient.
Magnetic resonance cholangiopancreatography (MRCP) is selected.
MRCP non-invasively confirms the presence of a common bile duct stone before subjecting the patient to the risks of an invasive therapeutic procedure.

Key Concept

Patients at intermediate risk for choledocholithiasis (abnormal liver chemistries and common bile duct dilation, but bilirubin < 4.0 mg/dL and no cholangitis) should undergo non-invasive confirmatory imaging with MRCP or endoscopic ultrasound before therapeutic intervention.

Alternative Method

Endoscopic ultrasound (EUS) is an equally appropriate, minimally invasive alternative to MRCP in this clinical scenario, offering high sensitivity for distal CBD stones. Modality selection often depends on local institutional expertise and availability.
Estimated Time:1m 30s
Rate this question

Topics

Ordering Imaging Studies

More questions from this topic